1) Dr. Swapnil Hiremath presented at the CAMRT joint Congress from May 28-30, 2015 in Montreal, Quebec on contrast nephropathy.
2) He discussed risk factors for contrast nephropathy including diabetes, dehydration, and severe chronic kidney disease. He also reviewed evidence for interventions to prevent contrast nephropathy such as N-acetyl cysteine, bicarbonate-based hydration, safer contrast media, and dialysis after contrast exposure.
3) Based on meta-analyses and randomized controlled trials, N-acetyl cysteine, bicarbonate hydration, and iso-osmolar contrast media may be most effective at reducing the risk of
- The document discusses contrast-induced nephropathy (CIN), including its definition, pathogenesis, incidence and risk factors, prevention methods, and recommendations.
- CIN is defined as a 25% rise in serum creatinine within 3 days of a contrast procedure. It occurs most often in patients with pre-existing renal insufficiency or diabetes and can be prevented using hydration protocols, acetylcysteine, and sodium bicarbonate administration.
- The highest risk patients include those with a baseline creatinine over 177 umol/L or over 350 umol/L. Prevention focuses on intravenous hydration, acetylcysteine, and sodium bicarbonate along with using
Imaging in Acute Kidney Injury, how not to harm patientsJoel Topf
This document summarizes evidence on the use of imaging and dialysis techniques to minimize harm in patients with acute kidney injury. It finds that while hemodialysis is generally not effective at protecting the kidneys from contrast-induced nephrotoxicity, it may be beneficial in patients with the most severe kidney impairment. Preemptive hemofiltration initiated before and continued after contrast exposure is the most effective strategy shown in randomized trials to reduce the risk of nephrotoxicity and associated outcomes like need for dialysis and mortality. However, risk also depends on the specific gadolinium-based contrast agent used, with agents having higher stability and weaker binding to gadolinium posing lower risks like nephrogenic
This document discusses acute kidney injury (AKI). It defines AKI and outlines several classification systems including RIFLE and AKIN. Common causes of AKI in intensive care units are then discussed, including sepsis, surgery, low cardiac output, and hypovolaemia. Biomarkers for detecting AKI such as creatinine, cystatin-C and NGAL are also summarized. The document concludes with sections on prevention of AKI, renal replacement therapy (RRT) modalities, and references.
Este documento trata sobre el uso de medios de contraste en diferentes exámenes de imagen médica como rayos X, tomografía computarizada y resonancia magnética. Explica los tipos de medios de contraste, sus vías de administración y aplicaciones. También describe reacciones adversas potenciales y precauciones para su uso seguro.
A ppt about contrast nephropathy: basics, risk factors, comparison of preventive strategies.
critical review of POSEIDON trial and brief about PRESERVE trial.
Perioperative acute kidney injury case presentationShen-Chih Wang
1) Perioperative acute kidney injury (AKI) increases surgical mortality and morbidity and hospital costs. Careful preoperative screening can identify patients at high risk.
2) Risk factors for perioperative AKI include impaired clinical status, intraperitoneal or high-risk surgery, congestive heart failure, diabetes, older age, and chronic kidney disease.
3) Preventing perioperative AKI involves minimizing nephrotoxins, optimizing intravascular volume and hemodynamics through fluid administration and inotropes if needed, and excluding renal tract obstruction radiologically.
The document provides information on acute kidney injury (AKI), including:
1. It discusses the anatomy and function of the kidney and nephron.
2. It defines AKI and compares it to the older term acute renal failure (ARF), noting that AKI describes the full spectrum of injury from mild to severe.
3. It summarizes the stages of AKI severity according to the RIFLE criteria which classify AKI based on changes in serum creatinine and urine output.
Contrast-induced nephropathy (CIN) is a common cause of hospital-acquired acute kidney injury. The risk of developing CIN is highest in patients with preexisting chronic kidney disease, diabetes, or those receiving a high volume of contrast agent. Nonionic, low-osmolar contrast agents have been shown to reduce the risk of CIN compared to ionic, high-osmolar agents. Preventive strategies focus on minimizing contrast volume, adequate hydration, and avoiding nephrotoxic medications.
- The document discusses contrast-induced nephropathy (CIN), including its definition, pathogenesis, incidence and risk factors, prevention methods, and recommendations.
- CIN is defined as a 25% rise in serum creatinine within 3 days of a contrast procedure. It occurs most often in patients with pre-existing renal insufficiency or diabetes and can be prevented using hydration protocols, acetylcysteine, and sodium bicarbonate administration.
- The highest risk patients include those with a baseline creatinine over 177 umol/L or over 350 umol/L. Prevention focuses on intravenous hydration, acetylcysteine, and sodium bicarbonate along with using
Imaging in Acute Kidney Injury, how not to harm patientsJoel Topf
This document summarizes evidence on the use of imaging and dialysis techniques to minimize harm in patients with acute kidney injury. It finds that while hemodialysis is generally not effective at protecting the kidneys from contrast-induced nephrotoxicity, it may be beneficial in patients with the most severe kidney impairment. Preemptive hemofiltration initiated before and continued after contrast exposure is the most effective strategy shown in randomized trials to reduce the risk of nephrotoxicity and associated outcomes like need for dialysis and mortality. However, risk also depends on the specific gadolinium-based contrast agent used, with agents having higher stability and weaker binding to gadolinium posing lower risks like nephrogenic
This document discusses acute kidney injury (AKI). It defines AKI and outlines several classification systems including RIFLE and AKIN. Common causes of AKI in intensive care units are then discussed, including sepsis, surgery, low cardiac output, and hypovolaemia. Biomarkers for detecting AKI such as creatinine, cystatin-C and NGAL are also summarized. The document concludes with sections on prevention of AKI, renal replacement therapy (RRT) modalities, and references.
Este documento trata sobre el uso de medios de contraste en diferentes exámenes de imagen médica como rayos X, tomografía computarizada y resonancia magnética. Explica los tipos de medios de contraste, sus vías de administración y aplicaciones. También describe reacciones adversas potenciales y precauciones para su uso seguro.
A ppt about contrast nephropathy: basics, risk factors, comparison of preventive strategies.
critical review of POSEIDON trial and brief about PRESERVE trial.
Perioperative acute kidney injury case presentationShen-Chih Wang
1) Perioperative acute kidney injury (AKI) increases surgical mortality and morbidity and hospital costs. Careful preoperative screening can identify patients at high risk.
2) Risk factors for perioperative AKI include impaired clinical status, intraperitoneal or high-risk surgery, congestive heart failure, diabetes, older age, and chronic kidney disease.
3) Preventing perioperative AKI involves minimizing nephrotoxins, optimizing intravascular volume and hemodynamics through fluid administration and inotropes if needed, and excluding renal tract obstruction radiologically.
The document provides information on acute kidney injury (AKI), including:
1. It discusses the anatomy and function of the kidney and nephron.
2. It defines AKI and compares it to the older term acute renal failure (ARF), noting that AKI describes the full spectrum of injury from mild to severe.
3. It summarizes the stages of AKI severity according to the RIFLE criteria which classify AKI based on changes in serum creatinine and urine output.
Contrast-induced nephropathy (CIN) is a common cause of hospital-acquired acute kidney injury. The risk of developing CIN is highest in patients with preexisting chronic kidney disease, diabetes, or those receiving a high volume of contrast agent. Nonionic, low-osmolar contrast agents have been shown to reduce the risk of CIN compared to ionic, high-osmolar agents. Preventive strategies focus on minimizing contrast volume, adequate hydration, and avoiding nephrotoxic medications.
02 Sperati Prevention And Management Of Acute Renal Failureguest2379201
This document provides an overview of acute renal failure (ARF), including its causes, diagnosis, and management. It discusses evaluating ARF through markers like fractional excretion of sodium and urea, and differentiating prerenal from intrinsic renal causes. Treatment involves supportive care and potentially renal replacement therapy, though the optimal modality and dose of therapy remain unclear from clinical trials.
Jason, a 54-year-old man with a history of type 1 diabetes for 48 years, presents to the emergency room with abdominal pain, nausea, fatigue, and a fruity odor on his breath. His blood sugars have been elevated. His initial diagnosis is diabetic ketoacidosis, which is confirmed by blood tests showing high blood glucose, low pH and bicarbonate levels, and ketones in his blood and urine. Diabetic ketoacidosis occurs when blood sugars rise over 250mg/dl and the body breaks down fat and produces ketones due to lack of insulin. It can be life-threatening if untreated but with proper treatment of insulin and fluid replacement, the condition can be managed.
The document discusses the history and development of acute renal failure treatment from the first dialysis machines in the 1920s to modern biomarkers and therapies. It covers key events and discoveries like Dr. Kolff's first patient surviving hemodialysis in 1943. Classification systems for acute renal failure like RIFLE are presented along with the limitations of creatinine as a marker. Biomarkers like KIM-1 and NGAL are proposed as more accurate indicators of kidney injury. Differential diagnosis and treatment options such as renal replacement therapy are also summarized.
Contrast induced nephropathy (CIN) is agenerally reversible form of acute kidney injury (AKI) that occurs soon after the administration of radiocontrast media.
This document discusses acute kidney injury (AKI), including its definition, epidemiology, causes, diagnosis, and treatment approaches. It provides details on:
- AKI definitions including RIFLE and KDIGO criteria.
- Common causes of AKI including pre-renal, intrinsic renal, and post-renal etiologies.
- Diagnostic evaluation including blood and urine tests, imaging, and biomarkers.
- General treatment principles including fluid resuscitation, eliminating nephrotoxins, and initiating renal replacement therapy.
- Specific approaches for pre-renal, intrinsic renal, and post-renal AKI as well as infections, nephrotoxins, and complications.
A review of the investigation and management of diabetic ketoacidosis in newly diagnosed type I diabetes. Patient details have been changed and anonymised to protect the identity of the individual.
Acute Kidney Injury (AKI), also known as Acute Renal Failure, can be defined as an abrupt loss of kidney function over hours to days resulting in retention of waste products and electrolyte dysregulation. The document discusses the definition, epidemiology, classification, evaluation, and management of AKI. It provides details on the RIFLE and AKI Network classification systems. Common causes of AKI include acute tubular necrosis (ATN) due to ischemia, nephrotoxins, or endogenous factors. ATN is characterized by patchy necrosis of tubular epithelial cells and higher mortality is associated with more severe AKI and underlying comorbidities.
This document discusses diabetic ketoacidosis (DKA). It defines DKA as a condition characterized by hyperglycemia, ketosis, and acidosis. The pathogenesis of DKA involves insulin deficiency leading to increased glucose production and lipolysis. Diagnostic criteria for DKA include blood glucose over 250 mg/dL, pH below 7.3, and bicarbonate below 15 mEq/L. Management of DKA involves fluid resuscitation, insulin therapy to lower blood glucose levels, electrolyte replacement, and treating any precipitating causes. Transition to subcutaneous insulin therapy occurs once ketosis and acidosis are resolved.
A 35-year-old male auto driver was admitted with decreased urine output for 3 days and abdominal pain and fever for 10 days. Examination found pallor and abdominal tenderness. Tests showed acute kidney injury and a urine culture grew gram-negative bacilli. He was diagnosed with acute pyelonephritis likely caused by E. coli infection. He received IV and oral antibiotics and underwent hemodialysis. His kidney function and other lab values gradually improved with treatment.
1. Diabetic ketoacidosis (DKA) is a life-threatening complication of diabetes that requires careful fluid and electrolyte management to prevent cerebral edema and other complications.
2. Treatment involves slow intravenous fluid administration, low-dose insulin therapy, careful monitoring of glucose and electrolyte levels, and changing to oral or subcutaneous insulin when the patient's condition improves.
3. Cerebral edema, which can cause death or neurological impairment, is more likely if fluid administration is too rapid, insulin is given as a bolus, or sodium and glucose levels are not closely monitored during treatment. Careful management of fluids, electrolytes, insulin and glucose levels is required to safely resolve DKA.
CASE PRESENTATION ON DIABETIC KETOACIDOSIS (DKA)Aaromal Satheesh
This patient, an 11-year-old female, presented with diabetic ketoacidosis symptoms including fever, excessive urination and thirst. Laboratory tests found elevated blood sugar, urine ketones and dehydration. She was treated with IV fluids, insulin and monitoring of blood sugar and electrolytes. Her symptoms improved over time and she was discharged with a prescription for long-acting insulin and diet and lifestyle counseling.
Este documento describe diferentes tipos de medios de contraste utilizados en radiología, incluyendo medios de contraste positivos como el sulfato de bario y compuestos yodados, y medios de contraste negativos como el aire. También explica cómo funcionan, sus vías de administración, precauciones y posibles reacciones adversas.
DIABETIC KETOACIDOSIS PRESENTATION BY ROOMA KHALIDRooma Khalid
This document discusses diabetic ketoacidosis (DKA). It defines DKA and its signs and symptoms. DKA occurs more often in type 1 diabetes and is characterized by blood glucose over 250 mg/dl, blood pH below 7.3, and ketones in serum over 5 mEq/L. Proper treatment of DKA involves fluid replacement, insulin administration, and monitoring of blood glucose, electrolytes, and pH to correct dehydration, hyperglycemia, and acidosis. Failure to treat the patient's DKA led to worsening of her condition.
This document discusses acute kidney injury (AKI). It begins with the anatomy and function of the kidney, explaining that the nephron is the functional unit that produces urine. It then discusses definitions of AKI and acute renal failure (ARF), noting they are not synonymous, with AKI encompassing a spectrum of injury. Common causes of AKI are also summarized, including decreased renal perfusion, intrinsic renal disease, and urinary tract obstruction. Stages of AKI severity are described using the RIFLE criteria of Risk, Injury and Failure. Incidence of AKI in intensive care unit patients is estimated between 5-20% with high mortality.
Acute kidney injury (AKI) is a common condition characterized by a sudden decline in kidney function. It affects 5-7% of hospital admissions and 30% of intensive care unit admissions. The top causes of AKI in India are diarrheal diseases, sepsis, malaria, drug toxicity, and hospital-acquired injuries. Treatment focuses on optimizing fluid status and hemodynamics, removing nephrotoxins if possible, and initiating renal replacement therapy as needed based on the underlying cause and severity of AKI.
The document defines and describes the crash cart, which contains emergency equipment and medications needed to treat cardiac emergencies. It outlines the crash cart's history, contents, and proper arrangement according to hospital policy. The crash cart must be checked regularly by nurses to ensure it is fully stocked and functional. It provides a mobile station containing defibrillators, airway equipment, intravenous drugs, and other supplies to quickly respond to life-threatening situations.
Humanitarian aid and access to haemophilia careAlbert Farrugia
This document summarizes information presented at a conference on access to haemophilia care post humanitarian aid. It discusses global plasma collection and FVIII production, examples of humanitarian aid programs providing factor concentrates, and comparisons of factor prices between different countries and over time. Barriers to increasing global access to treatment and potential strategies for overcoming these barriers are also examined.
A Critical Appraisal of Nephrology RCTs 2017Meguid Nahas
This document provides a summary and critical analysis of recent nephrology randomized controlled trials from 2015-2017. It discusses the SPRINT trial which found benefits of intensive blood pressure control but questions the validity of the findings given the increased risk of adverse events. It also summarizes the EMPA-REG trial on empaglifozin but notes the renal outcomes were from a post-hoc analysis so were hypothesis generating only. For the radiocontrast nephropathy study, it emphasizes the risk depends on patient comorbidities. Regarding the belatacept transplant trial, it argues the post-hoc analyses were underpowered and questions the statistical approach taken. Throughout, it stresses the importance of critically evaluating validity, risks, and
Eurasian Forum Slides "The Modern Understanding of Statins from the Intervent...Alexander Kharlamov
These slides were presented at the Eurasian Forum "Medicine, Pharmacy and Public Health" on October 8-9th 2015 in Yekaterinburg, Russia. The report reviews the concerns of the cardiovascular burden exposing critical national risk factors and extremely high mortality rates with the special focus on atherosclerosis, statin drugs and emerging options of interventional cardiology in Russia. The role of blood cholesterol levels in cardiovascular disease (CVD) and the true effect of lipid-lowering therapy are debatable. In particular, whether statins actually decrease cardiac mortality and increase life expectancy is controversial. The statins have gone on to become a multi-billion dollar industry, but the expectation that CVD could be prevented or eliminated by simply reducing cholesterol appears unfounded. More recently, intracoronary imaging modalities have enabled detailed in vivo quantification and characterization of coronary atherosclerotic plaque, serial evaluation of atherosclerotic changes over time, and assessment of vascular responses to effective anti-atherosclerotic medications with a target to achieve atheroregression within Glagov phenomenon. The intensive lipid lowering can halt plaque progression and may even result in regression of coronary atheroma, but results remain very modest and controversial. Statins reduce fibrous tissue and amount of intramural lipids, but with very slight effect on necrotic core and detrimental accelerated calcium deposition. New generations of the lipid-lowering drugs and nanotechnologies amid the revolution in theranostics of atherosclerosis grant us with a hope to achieve atheroregression below 40% Glagovian threshold. Check out my profile (Dr. Alexander Kharlamov) in ResearchGate for more details.
- Patrick W. Serruys is the editor-in-chief of EuroIntervention, which has reached its 10th anniversary as the official journal of the European Association of Percutaneous Cardiovascular Interventions.
- Over the past 10 years, the journal has grown tremendously due to the need to publish impactful presentations from EuroPCR and innovations from young cardiologists, as well as its inclusion in PubMed and increasing impact factor.
- The editorial board has played a key role in the journal's success through their expertise, enthusiasm, and awareness of current developments in the field.
The document provides guidelines for intrapartum fetal monitoring. It discusses the physiology of fetal oxygenation and goals of monitoring, which are to detect hypoxia and prevent metabolic acidosis. Umbilical cord blood gas analysis can objectively measure acidosis and is recommended when hypoxia is suspected. Apgar scores and conditions like HIE are also discussed as they relate to hypoxia. Various reversible intrapartum events that can lead to fetal hypoxia are outlined, such as excessive uterine activity, cord compression, and maternal position.
This document evaluates laboratory tests for diagnosing cirrhosis and detecting alcohol use in patients with alcoholic cirrhosis. It compares test results between 1578 patients with and without alcoholic cirrhosis, and between cirrhotic patients who were recently drinking or abstinent. International normalized ratio (INR) and bilirubin best distinguished cirrhotic from non-cirrhotic patients, with areas under the ROC curve of 0.91 and 0.88 respectively. Gamma glutamyl transferase (GGT) and aspartate aminotransferase (AST) detected recent drinking in cirrhotic patients using appropriate cut-off values, even in those without ascites. INR and bilirubin are most accurate for diagn
02 Sperati Prevention And Management Of Acute Renal Failureguest2379201
This document provides an overview of acute renal failure (ARF), including its causes, diagnosis, and management. It discusses evaluating ARF through markers like fractional excretion of sodium and urea, and differentiating prerenal from intrinsic renal causes. Treatment involves supportive care and potentially renal replacement therapy, though the optimal modality and dose of therapy remain unclear from clinical trials.
Jason, a 54-year-old man with a history of type 1 diabetes for 48 years, presents to the emergency room with abdominal pain, nausea, fatigue, and a fruity odor on his breath. His blood sugars have been elevated. His initial diagnosis is diabetic ketoacidosis, which is confirmed by blood tests showing high blood glucose, low pH and bicarbonate levels, and ketones in his blood and urine. Diabetic ketoacidosis occurs when blood sugars rise over 250mg/dl and the body breaks down fat and produces ketones due to lack of insulin. It can be life-threatening if untreated but with proper treatment of insulin and fluid replacement, the condition can be managed.
The document discusses the history and development of acute renal failure treatment from the first dialysis machines in the 1920s to modern biomarkers and therapies. It covers key events and discoveries like Dr. Kolff's first patient surviving hemodialysis in 1943. Classification systems for acute renal failure like RIFLE are presented along with the limitations of creatinine as a marker. Biomarkers like KIM-1 and NGAL are proposed as more accurate indicators of kidney injury. Differential diagnosis and treatment options such as renal replacement therapy are also summarized.
Contrast induced nephropathy (CIN) is agenerally reversible form of acute kidney injury (AKI) that occurs soon after the administration of radiocontrast media.
This document discusses acute kidney injury (AKI), including its definition, epidemiology, causes, diagnosis, and treatment approaches. It provides details on:
- AKI definitions including RIFLE and KDIGO criteria.
- Common causes of AKI including pre-renal, intrinsic renal, and post-renal etiologies.
- Diagnostic evaluation including blood and urine tests, imaging, and biomarkers.
- General treatment principles including fluid resuscitation, eliminating nephrotoxins, and initiating renal replacement therapy.
- Specific approaches for pre-renal, intrinsic renal, and post-renal AKI as well as infections, nephrotoxins, and complications.
A review of the investigation and management of diabetic ketoacidosis in newly diagnosed type I diabetes. Patient details have been changed and anonymised to protect the identity of the individual.
Acute Kidney Injury (AKI), also known as Acute Renal Failure, can be defined as an abrupt loss of kidney function over hours to days resulting in retention of waste products and electrolyte dysregulation. The document discusses the definition, epidemiology, classification, evaluation, and management of AKI. It provides details on the RIFLE and AKI Network classification systems. Common causes of AKI include acute tubular necrosis (ATN) due to ischemia, nephrotoxins, or endogenous factors. ATN is characterized by patchy necrosis of tubular epithelial cells and higher mortality is associated with more severe AKI and underlying comorbidities.
This document discusses diabetic ketoacidosis (DKA). It defines DKA as a condition characterized by hyperglycemia, ketosis, and acidosis. The pathogenesis of DKA involves insulin deficiency leading to increased glucose production and lipolysis. Diagnostic criteria for DKA include blood glucose over 250 mg/dL, pH below 7.3, and bicarbonate below 15 mEq/L. Management of DKA involves fluid resuscitation, insulin therapy to lower blood glucose levels, electrolyte replacement, and treating any precipitating causes. Transition to subcutaneous insulin therapy occurs once ketosis and acidosis are resolved.
A 35-year-old male auto driver was admitted with decreased urine output for 3 days and abdominal pain and fever for 10 days. Examination found pallor and abdominal tenderness. Tests showed acute kidney injury and a urine culture grew gram-negative bacilli. He was diagnosed with acute pyelonephritis likely caused by E. coli infection. He received IV and oral antibiotics and underwent hemodialysis. His kidney function and other lab values gradually improved with treatment.
1. Diabetic ketoacidosis (DKA) is a life-threatening complication of diabetes that requires careful fluid and electrolyte management to prevent cerebral edema and other complications.
2. Treatment involves slow intravenous fluid administration, low-dose insulin therapy, careful monitoring of glucose and electrolyte levels, and changing to oral or subcutaneous insulin when the patient's condition improves.
3. Cerebral edema, which can cause death or neurological impairment, is more likely if fluid administration is too rapid, insulin is given as a bolus, or sodium and glucose levels are not closely monitored during treatment. Careful management of fluids, electrolytes, insulin and glucose levels is required to safely resolve DKA.
CASE PRESENTATION ON DIABETIC KETOACIDOSIS (DKA)Aaromal Satheesh
This patient, an 11-year-old female, presented with diabetic ketoacidosis symptoms including fever, excessive urination and thirst. Laboratory tests found elevated blood sugar, urine ketones and dehydration. She was treated with IV fluids, insulin and monitoring of blood sugar and electrolytes. Her symptoms improved over time and she was discharged with a prescription for long-acting insulin and diet and lifestyle counseling.
Este documento describe diferentes tipos de medios de contraste utilizados en radiología, incluyendo medios de contraste positivos como el sulfato de bario y compuestos yodados, y medios de contraste negativos como el aire. También explica cómo funcionan, sus vías de administración, precauciones y posibles reacciones adversas.
DIABETIC KETOACIDOSIS PRESENTATION BY ROOMA KHALIDRooma Khalid
This document discusses diabetic ketoacidosis (DKA). It defines DKA and its signs and symptoms. DKA occurs more often in type 1 diabetes and is characterized by blood glucose over 250 mg/dl, blood pH below 7.3, and ketones in serum over 5 mEq/L. Proper treatment of DKA involves fluid replacement, insulin administration, and monitoring of blood glucose, electrolytes, and pH to correct dehydration, hyperglycemia, and acidosis. Failure to treat the patient's DKA led to worsening of her condition.
This document discusses acute kidney injury (AKI). It begins with the anatomy and function of the kidney, explaining that the nephron is the functional unit that produces urine. It then discusses definitions of AKI and acute renal failure (ARF), noting they are not synonymous, with AKI encompassing a spectrum of injury. Common causes of AKI are also summarized, including decreased renal perfusion, intrinsic renal disease, and urinary tract obstruction. Stages of AKI severity are described using the RIFLE criteria of Risk, Injury and Failure. Incidence of AKI in intensive care unit patients is estimated between 5-20% with high mortality.
Acute kidney injury (AKI) is a common condition characterized by a sudden decline in kidney function. It affects 5-7% of hospital admissions and 30% of intensive care unit admissions. The top causes of AKI in India are diarrheal diseases, sepsis, malaria, drug toxicity, and hospital-acquired injuries. Treatment focuses on optimizing fluid status and hemodynamics, removing nephrotoxins if possible, and initiating renal replacement therapy as needed based on the underlying cause and severity of AKI.
The document defines and describes the crash cart, which contains emergency equipment and medications needed to treat cardiac emergencies. It outlines the crash cart's history, contents, and proper arrangement according to hospital policy. The crash cart must be checked regularly by nurses to ensure it is fully stocked and functional. It provides a mobile station containing defibrillators, airway equipment, intravenous drugs, and other supplies to quickly respond to life-threatening situations.
Humanitarian aid and access to haemophilia careAlbert Farrugia
This document summarizes information presented at a conference on access to haemophilia care post humanitarian aid. It discusses global plasma collection and FVIII production, examples of humanitarian aid programs providing factor concentrates, and comparisons of factor prices between different countries and over time. Barriers to increasing global access to treatment and potential strategies for overcoming these barriers are also examined.
A Critical Appraisal of Nephrology RCTs 2017Meguid Nahas
This document provides a summary and critical analysis of recent nephrology randomized controlled trials from 2015-2017. It discusses the SPRINT trial which found benefits of intensive blood pressure control but questions the validity of the findings given the increased risk of adverse events. It also summarizes the EMPA-REG trial on empaglifozin but notes the renal outcomes were from a post-hoc analysis so were hypothesis generating only. For the radiocontrast nephropathy study, it emphasizes the risk depends on patient comorbidities. Regarding the belatacept transplant trial, it argues the post-hoc analyses were underpowered and questions the statistical approach taken. Throughout, it stresses the importance of critically evaluating validity, risks, and
Eurasian Forum Slides "The Modern Understanding of Statins from the Intervent...Alexander Kharlamov
These slides were presented at the Eurasian Forum "Medicine, Pharmacy and Public Health" on October 8-9th 2015 in Yekaterinburg, Russia. The report reviews the concerns of the cardiovascular burden exposing critical national risk factors and extremely high mortality rates with the special focus on atherosclerosis, statin drugs and emerging options of interventional cardiology in Russia. The role of blood cholesterol levels in cardiovascular disease (CVD) and the true effect of lipid-lowering therapy are debatable. In particular, whether statins actually decrease cardiac mortality and increase life expectancy is controversial. The statins have gone on to become a multi-billion dollar industry, but the expectation that CVD could be prevented or eliminated by simply reducing cholesterol appears unfounded. More recently, intracoronary imaging modalities have enabled detailed in vivo quantification and characterization of coronary atherosclerotic plaque, serial evaluation of atherosclerotic changes over time, and assessment of vascular responses to effective anti-atherosclerotic medications with a target to achieve atheroregression within Glagov phenomenon. The intensive lipid lowering can halt plaque progression and may even result in regression of coronary atheroma, but results remain very modest and controversial. Statins reduce fibrous tissue and amount of intramural lipids, but with very slight effect on necrotic core and detrimental accelerated calcium deposition. New generations of the lipid-lowering drugs and nanotechnologies amid the revolution in theranostics of atherosclerosis grant us with a hope to achieve atheroregression below 40% Glagovian threshold. Check out my profile (Dr. Alexander Kharlamov) in ResearchGate for more details.
- Patrick W. Serruys is the editor-in-chief of EuroIntervention, which has reached its 10th anniversary as the official journal of the European Association of Percutaneous Cardiovascular Interventions.
- Over the past 10 years, the journal has grown tremendously due to the need to publish impactful presentations from EuroPCR and innovations from young cardiologists, as well as its inclusion in PubMed and increasing impact factor.
- The editorial board has played a key role in the journal's success through their expertise, enthusiasm, and awareness of current developments in the field.
The document provides guidelines for intrapartum fetal monitoring. It discusses the physiology of fetal oxygenation and goals of monitoring, which are to detect hypoxia and prevent metabolic acidosis. Umbilical cord blood gas analysis can objectively measure acidosis and is recommended when hypoxia is suspected. Apgar scores and conditions like HIE are also discussed as they relate to hypoxia. Various reversible intrapartum events that can lead to fetal hypoxia are outlined, such as excessive uterine activity, cord compression, and maternal position.
This document evaluates laboratory tests for diagnosing cirrhosis and detecting alcohol use in patients with alcoholic cirrhosis. It compares test results between 1578 patients with and without alcoholic cirrhosis, and between cirrhotic patients who were recently drinking or abstinent. International normalized ratio (INR) and bilirubin best distinguished cirrhotic from non-cirrhotic patients, with areas under the ROC curve of 0.91 and 0.88 respectively. Gamma glutamyl transferase (GGT) and aspartate aminotransferase (AST) detected recent drinking in cirrhotic patients using appropriate cut-off values, even in those without ascites. INR and bilirubin are most accurate for diagn
The document discusses various tools for assessing the environmental impacts of products and services, including life cycle assessment (LCA). It provides an overview of LCA methodology and describes its strengths and weaknesses. It also gives an example of how a civil society organization used LCA results in a campaign that influenced Swedish tomato producers to switch to biofuels in their greenhouses. Environmental input-output analysis is also introduced as a tool to study relationships between economic sectors and their environmental impacts.
This document summarizes a teleconference discussing the cost-effectiveness of various cardiovascular disease therapies. It provides cost-effectiveness ratios for therapies such as statins, clopidogrel, and eplerenone. It also discusses the high costs of post-MI heart failure and the benefits and cost-effectiveness of eplerenone in reducing mortality and hospitalization in MI patients with left ventricular dysfunction.
This document discusses oral anticoagulants (OACs) for preventing thromboembolic events in patients with atrial fibrillation (AF). It outlines the rationale for using OACs in AF patients, different types of OACs including vitamin K antagonists and novel oral anticoagulants (NOACs), and clinical trial results demonstrating the efficacy and safety of NOACs compared to warfarin. It also discusses calculating the net clinical benefit of OACs, guidelines for indications of anticoagulation treatment, factors to consider when selecting an OAC, and conclusions regarding the effectiveness and appropriate use of OACs in AF patients.
What does research tell us about alcohol related health risksTHL
This document discusses setting low-risk drinking guidelines in the EU. It describes work by the Joint Action on Reducing Alcohol Related Harm project to summarize scientific evidence on health risks of alcohol consumption for 7 EU countries. The project team calculated lifetime mortality risks for alcohol consumption levels to inform guideline discussions. Results showed differences between countries due to varying disease patterns. Guidelines balance drawing clear risk lines with accounting for disease and gender differences. Calculations provide data for individual countries to assess risks and derive guidelines.
Fundación EPIC _ Left atrial appendage closure. Clinical evidence; where we a...Fundacion EPIC
Presentación de la ponencia "Cierre Percutáneo de Orejuela Izquierda. Evidencia clínica: dónde estamos?" realizada por Raul Moreno en los Diálogos EPIC_Cierre Percutáneo de la Orejuela Izquierda el 15 de Marzo de 2018 en Madrid (España)
Left atrial appendage closure. Clinical evidence; where we are? by Raul Moreno at Diálogos EPIC_Percutaneous left atrial appendage closure, March 15th 2018 in Madrid (Spain)
The document discusses guidelines from the Canadian Cardiovascular Society for the management of dyslipidemia to prevent cardiovascular disease. It provides recommendations on screening, risk assessment, pharmacological treatment indications and targets, and monitoring. Key points include recommending non-fasting lipid screening, treating high risk groups with statins to achieve an LDL-C target of <2.0 mmol/L, and using ezetimibe as second-line therapy if targets are not reached with statins alone. The guidelines were developed using the GRADE process and are intended to help optimize dyslipidemia management and reduce cardiovascular risk.
This document summarizes postmarketing studies comparing the Russian-made Calypso drug-eluting stent to analogous foreign stents. It describes two ongoing comparative registry studies - E-Calypso and Patriot - that are evaluating the safety and efficacy of the Calypso stent versus competitors like the Resolute Integrity and Xience Prime stents. The document outlines the study designs, endpoints, inclusion/exclusion criteria and administrative details of the comparative studies which are taking place in Russia through 2016. It also provides technical specifications and performance data indicating the Calypso stent is competitive with leading foreign stents while offering significant cost savings.
This document summarizes literature on conventional aortic valve replacement. It finds that while mortality from the procedure has decreased over time, risks increase with age, renal failure, and urgency of the procedure. Long-term survival is lower in older patients and those with comorbidities. Both bioprosthetic and mechanical valves have risks, with bioprosthetic valves facing durability issues and mechanical valves risks of thromboembolism and bleeding. However, studies found non-inferior outcomes for mechanical valves in younger patients (<65) with close anticoagulation monitoring compared to bioprosthetic valves. The conclusion is that while bioprosthetic valves are increasingly used in all patients, mechanical valves can provide good long-
Dr. Osama El-Shahat discusses various aspects of acute kidney injury (AKI) management including staging, modalities of renal replacement therapy, and general principles. The document covers (1) staging systems like RIFLE and AKIN to classify AKI severity, (2) modalities like intermittent hemodialysis, slow continuous ultrafiltration, and continuous renal replacement therapy, and (3) general guidelines around initiating renal replacement therapy, vascular access, solutions, anticoagulation, and dose of therapy. The overall message is that managing AKI requires an individualized approach and more high-quality research is still needed.
This document provides highlights of Wiley's journal portfolio across various scientific disciplines. Some key details:
- Wiley publishes over 278 journals across physical sciences, chemistry, materials science, polymer science, physics, engineering, mathematics, and statistics. Many of these journals are ranked highly in the Journal Citation Reports.
- Wiley has partnerships with over 90 academic societies worldwide, allowing them to publish society journals and connect with over 500,000 society members.
- Six of Wiley's physical sciences journals and 15 chemistry journals are ranked #1 in their Journal Citation Reports categories. Overall many Wiley journals are ranked in the top 10 of their fields.
This document discusses contrast agents used in angiography and factors related to contrast-induced nephropathy (CIN). It notes that the route of contrast administration, volume administered, and properties of the specific contrast agent can influence CIN risk. Low-osmolar contrast agents are associated with less adverse effects than ionic agents. Hydration before and after the procedure can help reduce CIN incidence. Gadolinium may be considered as an alternative to iodinated contrast for patients at high risk of CIN.
Similar to Contrast-induced Acute Kidney Injury (20)
These lecture slides, by Dr Sidra Arshad, offer a simplified look into the mechanisms involved in the regulation of respiration:
Learning objectives:
1. Describe the organisation of respiratory center
2. Describe the nervous control of inspiration and respiratory rhythm
3. Describe the functions of the dorsal and respiratory groups of neurons
4. Describe the influences of the Pneumotaxic and Apneustic centers
5. Explain the role of Hering-Breur inflation reflex in regulation of inspiration
6. Explain the role of central chemoreceptors in regulation of respiration
7. Explain the role of peripheral chemoreceptors in regulation of respiration
8. Explain the regulation of respiration during exercise
9. Integrate the respiratory regulatory mechanisms
10. Describe the Cheyne-Stokes breathing
Study Resources:
1. Chapter 42, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 36, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 13, Human Physiology by Lauralee Sherwood, 9th edition
NAVIGATING THE HORIZONS OF TIME LAPSE EMBRYO MONITORING.pdfRahul Sen
Time-lapse embryo monitoring is an advanced imaging technique used in IVF to continuously observe embryo development. It captures high-resolution images at regular intervals, allowing embryologists to select the most viable embryos for transfer based on detailed growth patterns. This technology enhances embryo selection, potentially increasing pregnancy success rates.
Nano-gold for Cancer Therapy chemistry investigatory projectSIVAVINAYAKPK
chemistry investigatory project
The development of nanogold-based cancer therapy could revolutionize oncology by providing a more targeted, less invasive treatment option. This project contributes to the growing body of research aimed at harnessing nanotechnology for medical applications, paving the way for future clinical trials and potential commercial applications.
Cancer remains one of the leading causes of death worldwide, prompting the need for innovative treatment methods. Nanotechnology offers promising new approaches, including the use of gold nanoparticles (nanogold) for targeted cancer therapy. Nanogold particles possess unique physical and chemical properties that make them suitable for drug delivery, imaging, and photothermal therapy.
- Video recording of this lecture in English language: https://youtu.be/Pt1nA32sdHQ
- Video recording of this lecture in Arabic language: https://youtu.be/uFdc9F0rlP0
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Histololgy of Female Reproductive System.pptxAyeshaZaid1
Dive into an in-depth exploration of the histological structure of female reproductive system with this comprehensive lecture. Presented by Dr. Ayesha Irfan, Assistant Professor of Anatomy, this presentation covers the Gross anatomy and functional histology of the female reproductive organs. Ideal for students, educators, and anyone interested in medical science, this lecture provides clear explanations, detailed diagrams, and valuable insights into female reproductive system. Enhance your knowledge and understanding of this essential aspect of human biology.
“Psychiatry and the Humanities”: An Innovative Course at the University of Mo...Université de Montréal
“Psychiatry and the Humanities”: An Innovative Course at the University of Montreal Expanding the medical model to embrace the humanities. Link: https://www.psychiatrictimes.com/view/-psychiatry-and-the-humanities-an-innovative-course-at-the-university-of-montreal
Travel vaccination in Manchester offers comprehensive immunization services for individuals planning international trips. Expert healthcare providers administer vaccines tailored to your destination, ensuring you stay protected against various diseases. Conveniently located clinics and flexible appointment options make it easy to get the necessary shots before your journey. Stay healthy and travel with confidence by getting vaccinated in Manchester. Visit us: www.nxhealthcare.co.uk
Computer in pharmaceutical research and development-Mpharm(Pharmaceutics)MuskanShingari
Statistics- Statistics is the science of collecting, organizing, presenting, analyzing and interpreting numerical data to assist in making more effective decisions.
A statistics is a measure which is used to estimate the population parameter
Parameters-It is used to describe the properties of an entire population.
Examples-Measures of central tendency Dispersion, Variance, Standard Deviation (SD), Absolute Error, Mean Absolute Error (MAE), Eigen Value
Computer in pharmaceutical research and development-Mpharm(Pharmaceutics)
Contrast-induced Acute Kidney Injury
1. May 28 – 30, 2015, Montréal, Québec
Contrast Nephropathy
Swapnil Hiremath, MD, MPH
@hswapnil
Nephrologist
The Ottawa Hospital
University of Ottawa
Ottawa Hospital Research Institute
2. May 28 – 30, 2015, Montréal, Québec
Disclosure Statement: With a Conflict of Interest
Financial:
• Study funding: GE Healthcare is funding an economic analysis to study the
impact of osmolality of contrast medium and acute kidney injury
• I own no stock or securities nor do I serve or have served as a consultant
for any drug or device manufacturer
Others:
• I am the PI of an ongoing trial examining oral hydration (vs IV) to prevent
contrast nephropathy
• I am a co-author of the Canadian Association of Radiology (CAR)
guidelines
3. CAMRT joint Congress May 2015
Objectives
At the end of this talk, the listener will
• Identify patients who are at high risk of contrast
nephropathy
• Know what to order to minimize risk of
contrast nephropathy
4. CAMRT joint Congress May 2015
What is Contrast
Nephropathy*?
*Now known as
Contrast-induced
Acute Kidney Injury
Following Contrast
exposure:
Arterial (cardiac cath,
arteriograms)
Venous (CT Scans)
5. CAMRT joint Congress May 2015
What is Contrast
Nephropathy*?
• Acute Kidney Injury,
defined as:
• Rise in creatinine of
25%
• Rise in creatinine of
44 micromol/L
• A much smaller
proportion: Dialysis
or Death
*Now known as
Contrast-induced
Acute Kidney Injury
Following Contrast
exposure:
Arterial (cardiac cath,
arteriograms)
Venous (CT Scans)
14. CAMRT joint Congress May 2015
Which patients are at risk?
• Arterial contrast (Cardiac Catheterization,
Angiograms) >>Venous Contrast (Contrast
enhanced CT scans)
15. CAMRT joint Congress May 2015
Which patients are at risk?
• Arterial contrast (Cardiac Catheterization,
Angiograms) >>Venous Contrast (Contrast
enhanced CT scans)
• Diabetes, Dehydration
16. CAMRT joint Congress May 2015
Which patients are at risk?
• Arterial contrast (Cardiac Catheterization,
Angiograms) >>Venous Contrast (Contrast
enhanced CT scans)
• Diabetes, Dehydration
• Severe Chronic Kidney Disease (eGFR <
30, stage 4 and 5 CKD)
17. CAMRT joint Congress May 2015
How should we prevent Contrast - AKI?
Literature Roundup
>8000 publications
14 + 57 + 22 + 18
=113 RCTs
(4 interventions)
3412 with RCT
filter
42 Meta-
analyses
18. CAMRT joint Congress May 2015
How should we prevent Contrast - AKI?
Literature Roundup
>8000 publications
14 + 57 + 22 + 18
=113 RCTs
(4 interventions)
3412 with RCT
filter
42 Meta-
analyses
+ 82 studies
currently recruiting
(per
Clinicaltrials.gov)
65. CAMRT joint Congress May 2015
Comparison of Effect Sizes
Intervention First Study
Best
Study
N-Acetyl Cysteine 0.1 1.01
Bicarb-based Hydration 0.125 0.94
Dialysis after Contrast 0.1 0.90
Iso-osmolar vs low-
osmolar Contrast
0.09 1.13
66. CAMRT joint Congress May 2015
Comparison of Effect Sizes
Intervention First Study
Best
Study
N-Acetyl Cysteine 0.1 1.01
Bicarb-based Hydration 0.125 0.94
Dialysis after Contrast 0.1 0.90
Iso-osmolar vs low-
osmolar Contrast
0.09 1.13
67. CAMRT joint Congress May 2015
Comparison of Effect Sizes
Intervention First Study
Best
Study
N-Acetyl Cysteine 0.1 1.01
Bicarb-based Hydration 0.125 0.94
Dialysis after Contrast 0.1 0.90
Iso-osmolar vs low-
osmolar Contrast
0.09 1.13
68. CAMRT joint Congress May 2015
Comparison of Effect Sizes
Intervention
First
Study
Best
Study
N-Acetyl
Cysteine
0.1
NEJM
1.01
CirculationN-Acetyl
Cysteine
0.1
N = 83
1.01
N =2400
Bicarb-based
Hydration
0.125
JAMA
0.94
JAMABicarb-based
Hydration
0.125
N =119
0.94
N = 353
Dialysis after
Contrast
0.1
NEJM
0.90
CRCDialysis after
Contrast
0.1
N = 114
0.90
N = 424
Iso-osmolar
Contrast
0.09
NEJM
1.13
JACCIso-osmolar
Contrast
0.09
N = 129
1.13
N = 418
69. CAMRT joint Congress May 2015
Contrast media
DoesVenous Contrast
cause Acute Kidney
Injury?
70. CAMRT joint Congress May 2015
Contrast media Acute Kidney Injury
DoesVenous Contrast
cause Acute Kidney
Injury?
71. CAMRT joint Congress May 2015
Contrast media Acute Kidney Injury
DoesVenous Contrast
cause Acute Kidney
Injury?
72. CAMRT joint Congress May 2015
Contrast media Acute Kidney Injury
Sepsis
Cardiogenic Shock
DoesVenous Contrast
cause Acute Kidney
Injury?
73. CAMRT joint Congress May 2015
Contrast media Acute Kidney Injury
Sepsis
Cardiogenic Shock
DoesVenous Contrast
cause Acute Kidney
Injury?
74. CAMRT joint Congress May 2015
Contrast-
induced
Contrast media Acute Kidney Injury
Sepsis
Cardiogenic Shock
DoesVenous Contrast
cause Acute Kidney
Injury?
75. CAMRT joint Congress May 2015
Contrast-
associated
Contrast media Acute Kidney Injury
Sepsis
Cardiogenic Shock
DoesVenous Contrast
cause Acute Kidney
Injury?
76. CAMRT joint Congress May 2015
DoesVenous Contrast
Cause AKI?
Source: Radiology, 2014
77. CAMRT joint Congress May 2015
DoesVenous Contrast
Cause AKI?
Source: Radiology, 2014
78. CAMRT joint Congress May 2015
Others
• If hydration helps, so will stopping diuretics
• Potentially nephrotoxic medications: NSAIDs,
others
• RAS Blockade? (ACE inhibitors,Angiotensin
receptor blockers, renin inhibitors,
spironolactone)
• Statins
80. CAMRT joint Congress May 2015
Metformin and Contrast?
• Metformin is NOT nephrotoxic;
phenformin, its predecessor was banned
for causing lactic acidosis. Case reports
exist with metformin as well
81. CAMRT joint Congress May 2015
Metformin and Contrast?
• Metformin is NOT nephrotoxic;
phenformin, its predecessor was banned
for causing lactic acidosis. Case reports
exist with metformin as well
• So, if a patient is on metformin AND
82. CAMRT joint Congress May 2015
Metformin and Contrast?
• Metformin is NOT nephrotoxic;
phenformin, its predecessor was banned
for causing lactic acidosis. Case reports
exist with metformin as well
• So, if a patient is on metformin AND
• Is given contrast AND
83. CAMRT joint Congress May 2015
Metformin and Contrast?
• Metformin is NOT nephrotoxic;
phenformin, its predecessor was banned
for causing lactic acidosis. Case reports
exist with metformin as well
• So, if a patient is on metformin AND
• Is given contrast AND
• Develops severe AKI (GFR <20) AND
84. CAMRT joint Congress May 2015
Metformin and Contrast?
• Metformin is NOT nephrotoxic;
phenformin, its predecessor was banned
for causing lactic acidosis. Case reports
exist with metformin as well
• So, if a patient is on metformin AND
• Is given contrast AND
• Develops severe AKI (GFR <20) AND
• Metformin is not stopped THEN
85. CAMRT joint Congress May 2015
Metformin and Contrast?
• Metformin is NOT nephrotoxic;
phenformin, its predecessor was banned
for causing lactic acidosis. Case reports
exist with metformin as well
• So, if a patient is on metformin AND
• Is given contrast AND
• Develops severe AKI (GFR <20) AND
• Metformin is not stopped THEN
• There is a possibility of lactic acidosis
86. CAMRT joint Congress May 2015
Metformin and Contrast?
‘ The legacy of phenformin, anecdotes,
scattered case reports, product inserts
and medicolegal anxieties are more at
the heart of this issue than scientific
fact’ - Gerald Pond, Radiology, 2001
88. CAMRT joint Congress May 2015
Summary
• Contrast procedures have become safer with
time
89. CAMRT joint Congress May 2015
Summary
• Contrast procedures have become safer with
time
• IV (eg CT scans) contrast is considerably less
harmful than IA contrast (eg cardiac cath)
90. CAMRT joint Congress May 2015
Summary
• Contrast procedures have become safer with
time
• IV (eg CT scans) contrast is considerably less
harmful than IA contrast (eg cardiac cath)
• CKD stage 4 & 5 (GFR < 30) might still be at risk
of AKI with CT Scans
91. CAMRT joint Congress May 2015
Summary
• Contrast procedures have become safer with
time
• IV (eg CT scans) contrast is considerably less
harmful than IA contrast (eg cardiac cath)
• CKD stage 4 & 5 (GFR < 30) might still be at risk
of AKI with CT Scans
• Most prophylactic measures (bicarb, NAC,
dialysis) don’t work; except for volume expansion
92. CAMRT joint Congress May 2015
Thank you
• Email:
shiremath@toh.on.ca
• Twitter: @hswapnil
• https://about.me/
swapnil.hiremath